Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 5:14 PM UTC
| NCT Number | NCT07785609 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 15, 2026 (1 week ago) |
As of October 22, 2026: Clinical trial NCT07785609 is currently recruiting participants. This phase2 study for advanced solid tumors is actively seeking new participants at 1 location across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07785609 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07785609 was last updated 1 week ago (October 15, 2026). HelloStudys verifies this status automatically.